Assessment of visual function in patients with gyrate atrophy who are considered candidates for gene replacement.
暂无分享,去创建一个
[1] D. Valle,et al. Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[2] D. Sullivan,et al. Ornithine-δ-aminotransferase expression and ornithine metabolism in cultured epidermal keratinocytes: toward metabolic sink therapy for gyrate atrophy , 1997, Gene Therapy.
[3] C. Obie,et al. Ornithine delta-aminotransferase mutations in gyrate atrophy. Allelic heterogeneity and functional consequences. , 1992, The Journal of biological chemistry.
[4] M. Kaiser-Kupfer,et al. Gyrate atrophy of the choroid and retina. Long-term reduction of ornithine slows retinal degeneration. , 1991, Archives of ophthalmology.
[5] H. Willard,et al. Human ornithine-delta-aminotransferase. cDNA cloning and analysis of the structural gene. , 1988, The Journal of biological chemistry.
[6] M. Sandberg,et al. Narrow-band filtering for monitoring low-amplitude cone electroretinograms in retinitis pigmentosa. , 1988, American journal of ophthalmology.
[7] R G Weleber,et al. Computerized quantitative analysis of kinetic visual fields. , 1986, American journal of ophthalmology.
[8] R. Milton,et al. The natural history of gyrate atrophy of the choroid and retina. , 1981, Ophthalmology.
[9] M. Kaiser-Kupfer,et al. Clinical and biochemical heterogeneity in gyrate atrophy. , 1980, American journal of ophthalmology.